Abstract
Background Viscosity affects flows by increasing resistance to movement; therefore, variations in blood viscosity (BV) levels could modify the cerebral blood flow.
Objective This study aimed to determine the level of correlation between BV and cerebral blood flow in people acclimated to chronic hypoxia who have high BV levels.
Methods Prospective observational study was conducted among clinically healthy young adults living in the city of Cusco (3,399 m above sea level). All participants were examined at low and high shear rates (75 and 300 sec−1) to simulate the dynamic component of BV. A transcranial Doppler study of the middle cerebral artery was performed to measure systolic, diastolic, and mean flow velocities (FVs) and resistance and pulsatility indices (PIs).
Results A total of 131 participants were included. The median viscosity levels were 5.01cP [interquartile range (IQR): 4.45–5.73cP] at 300 sec−1 and 6.16 cP [IQR: 5.58-7.20 cP] at 75 sec−1, the mean FV was 57 m/s [IQR: 50–65 m/s5], and the PI was 0.91 [0.86–1.02]. BV was negatively correlated with mean FV (r: −0.17, p=0.007), while it showed no correlation with other values of blood flow, resistance, or PI.
Conclusions Changes in BV levels have a minimal impact on the mean FV but not on other parameters. This finding suggests that in young and clinically healthy individuals, there are autoregulation mechanisms that compensate for BV variations, although they are not completely understood.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Fondo Nacional de Desarrollo Cientifico, Tecnologico y de Innovacion Tecnologica (FONDECYT Peru), code 378-2019, and Universidad Andina del Cusco.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the ethics and research committee of the Hospital Nacional Adolfo Guevara Velasco, EsSalud Cusco (resolution no. 419-GRACU-ESSALUD-2020)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Competing interests. The authors declare no competing interests
Funding: This work was supported by Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica (FONDECYT – Perú), code 378-2019, and Universidad Andina del Cusco.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos